Clinical Trial Update: Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial） [NA]

View source ↗

Summary

A clinical trial is evaluating percutaneous closure of patent foramen ovale as a treatment for drug-resistant epilepsy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy
• Epilepsy

Snippet

Sponsor: Sichuan University | Conditions: Epilepsy (treatment Refractory) | NA | Status: RECRUITING